- More than half of patients who are eligible to start statins say that they are not even offered them.
- Patients who are offered and refuse or discontinue cite side effects concerns.
- Patient willingness to take statins is high.
Why this matters
- These findings suggest unmet needs and untaken opportunities.
- An editorial accompanies the report.
- 59.2% of statin-eligible patients reported not having been offered them.
- Reporting this was likelier among women, black, and/or uninsured patients.
- 10.1% had declined the offer of a statin.
- 30.7% had started statins but discontinued.
- Most common reason for refusal or discontinuation was skepticism about safety:
- 70.4% of current users thought they were safe vs:
- 36.9% of those who declined, and
- 37.4% of those who discontinued.
- 67.7% who were never offered said they were willing to try statins.
- 59.7% who discontinued said they might reconsider.
- Data from 5693 patients in the Patient and Provider Assessment of Lipid Management registry.
- Surveyed about statin experiences, reasons for refusal, discontinuation, statin-related beliefs.
- Funding: Sanofi; Regeneron Pharmaceuticals; others.
- Statin use possibly overestimated.
- Self-report data, subject to recall bias.